NOAK vid ischemisk hjärtsjukdom och perifer ateroskleros
Engelsk titel: NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease
Läs online
Författare:
Gottsäter, Anders
Email: anders.gottsater@med.lu.se
Språk: Swe
Antal referenser: 23
Dokumenttyp:
Artikel
UI-nummer: 19010353
Sammanfattning
New oral anticoagulants (NOAC) have been introduced in Swedish health care as first line treatment of atrial fibrillation and venous thromboembolism. NOAC have also been studied in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease, and reduced doses will presumably emerge as routine treatment also in these conditions.